Keyphrases
Idiopathic Pulmonary Fibrosis
100%
Lung Transplantation
30%
Interstitial Lung Disease
26%
Sleep-disordered Breathing
17%
Macrophages
15%
Obstructive Sleep Apnea
14%
Hazard Ratio
13%
Interleukin-12 (IL-12)
13%
Disease Severity
12%
Quality of Life
11%
St. George's Respiratory Questionnaire
11%
Macrophage Accumulation
11%
Outcome Registry
11%
Oxygen Use
10%
Hospitalization
10%
Pulmonary Fibrosis
10%
Mortality Prediction
10%
Comorbidity
9%
Access to Palliative Care
8%
Clinical Trials
8%
Sleep Medicine
8%
Gene Association
8%
Reported Deaths
8%
Sectional Analysis
8%
Human Plasma Proteome
8%
Fibrosis-related Genes
8%
IL-12p40
8%
Positive Airway Pressure
8%
Allograft Dysfunction
8%
Epithelial Cells
8%
Positive Airway Pressure Therapy
8%
IL-12 Receptor
8%
Homodimer
8%
Peripheral Blood
8%
Patient-reported Outcomes
8%
Provider Perspectives
8%
Macrophage Chemotaxis
8%
Chemokine Receptor
8%
Matrix Metalloproteinases
8%
Molecular Imaging
8%
Chronic Allograft Dysfunction
8%
Fibrosis Biomarkers
8%
Tissue Inhibitor of metalloproteinase-1 (TIMP-1)
8%
Proteomic Profiling
8%
Viral Inflammation
8%
Older Men
8%
Antisynthetase Syndrome
8%
Dyspnea
8%
Chemoattractant
7%
Palliative Care
7%
Medicine and Dentistry
Idiopathic Pulmonary Fibrosis
64%
Lung Transplantation
28%
Obstructive Sleep Apnea
19%
Interstitial Lung Disease
17%
Disease Severity
14%
Hazard Ratio
13%
Quality of Life
13%
St. George Respiratory Questionnaire
11%
Lung
11%
Pulmonary Fibrosis
9%
Comorbidity
9%
Cross Sectional Study
8%
Symptomatic Treatment
8%
Patient-Reported Outcome
8%
Molecular Imaging
8%
Chemokine Receptor
8%
Dyspnea
8%
Antisynthetase Syndrome
8%
Positive Airway Pressure
8%
Matrix Metalloproteinase
8%
Metalloprotease Inhibitor
8%
DLCO
6%
Disease
6%
Prevalence
5%